Com eficácia de 85% em estudos iniciais, o Soluu se destaca frente aos tratamentos convencionais, que entregam eficiência entre 30% a 40%. N?o por acaso, a solu??o atraiu investidores, brasileiros e estrangeiros, e deu origem à?Global Continence Inc., empresa de capital híbrido, com sede nos Estados Unidos, avaliada em US$ 25 milh?es. #patrocinado
关于我们
Global Continence is a pioneering healthcare company dedicated to transforming the landscape of Nocturnal Enuresis (NE) treatment. Our flagship product, Soluu?, is a revolutionary bedwetting device that harnesses the power of neuromodulation and remote signaling through non-invasive transcutaneous nerve stimulation (TENS) and a user-friendly app. NE affects millions of children globally, causing emotional distress and posing challenges for families. Current treatments often fall short, leading to discontinuation due to discomfort or ineffectiveness. Soluu? aims to revolutionize NE treatment with over 80% success within two months, as demonstrated in initial studies. Our innovative device not only promises improved treatment outcomes but also alleviates the emotional and financial burden on families dealing with NE. Global Continence is committed to making a positive impact on the lives of children suffering from NE, striving to reduce the emotional and financial burden on families worldwide. Join us in our mission to bring Soluu? to market and create lasting change for those affected by this challenging condition. #GlobalContinence #Soluu #HealthcareInnovation
- 网站
-
www.globalcontinence.com
Global Continence Inc.的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 2-10 人
- 总部
- Atlanta，Georgia
- 类型
- 私人持股
地点
Global Continence Inc.员工
动态
-
Exciting developments at the University of Georgia: With a robust research enterprise exceeding $545.6 million in FY22, fueled in part by NIH funding, UGA stands at the forefront of biomedical innovation. The proposed establishment of an independent public medical school at UGA would position the institution uniquely among only 13 higher education institutions nationwide with comprehensive One Health (plant, animal, and human) research capabilities. This initiative aims to accelerate biomedical research, attract top-tier talent, and foster partnerships to address critical health issues. Join us in shaping the future of healthcare and research at UGA with The University of Georgia School of Medicine!